-11.9 kb -4.2 kb -5.6 kb Gfi1 +/1b neo Gfi1 +/+ Gfi1 +/1b Gfi1 1b/1b Gfi1 +/1b Gfi1 +/+ -11.9 kb - 4.2 kb Gfi1 +/+ Gfi1 +/1b -14 kb - 8 kb B A Gfi1 +/+

Slides:

Advertisements

Similar presentations

Slide 1Fig. 11.1, p.337. Slide 2Fig. 11.2, p.338.

Advertisements

Slide 1Fig. 19.1, p Slide 2Fig. 19.2, p. 583.

Slide 1Fig. 21.1, p.641. Slide 2Fig. 21.2, p.642.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

A 1 A 2 A 3 A 4 B B B

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Figure Figure 18-1 part 1 Figure 18-1 part 2.

1 times table 2 times table 3 times table 4 times table 5 times table

The Cell Division Cycle

Supplementary Figure Legends: Table 1. List of primers used for Real Time – PCR Supp Fig 1. S100A7-overexpressing MCF7 cells show decreased formation of.

4.6 Model Direct Variation

Figure S UV- UV+ Relative expression levels of rhoB mRNA by qRT-PCR *

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Tables Learning Support

Figure Molecular Biology of the Cell (© Garland Science 2008)

Figure 14-1 Molecular Biology of the Cell (© Garland Science 2008)

Invest. Ophthalmol. Vis. Sci ;47(1): doi: /iovs Figure Legend:

Progesterone receptor

Figure 12-13: Synchronous Binary Counter

Chapter 3 Derivatives.

Figures & Tables from the textbook.

rbx-1 RNAi treatment (against ZK287.5)

Differential Equations

© 2013 Elsevier, Inc. All rights reserved.

A IP: Proteintech anti-SK2 B IP: Proteintech anti-SK2 Ab SK2 IgG

HDAC3, but not HDAC2 is in complex with tau protein.

Ogami_Fig. S1 CPEB pHA-CMV Time (h) oligo(dT)/ RNase H

A B C D E Liver Survival Fit Csp12 -/- Csp12 +/+ Csp12-/- Csp12+/+

When Deletions Gain Functions: Commandeering Epigenetic Mechanisms

Volume 61, Issue 4, Pages (April 2002)

Critical Role of Complement and Viral Evasion of Complement in Acute, Persistent, and Latent γ-Herpesvirus Infection Sharookh B. Kapadia, Beth Levine,

sgSNP 377 Contig21552 sgSNP 247 Contig11105 sgSNP 1433 Contig10821

a b c d * MCF7.vec MCF7 IP: HA HA IgG p110 p  p85WT p85S83μ

the common cytokine receptor g chain,

EDLC(Embedded system Development Life Cycle ).

IL-6 is dispensable for the suppressive activity of MDSC on primary CD4+ T-cell activation. IL-6 is dispensable for the suppressive activity of MDSC on.

Volume 23, Issue 5, Pages (November 2005)

IL-18, but Not IL-12, Induces Production of IFN-γ in the Immunosuppressive Environment of HPV16 E7 Transgenic Hyperplastic Skin Christina Gosmann, Ian.

Einar K. Rofstad, Bjørn A. Graff Journal of Investigative Dermatology

Figure 3. MAb 19H9 displays broad cross-reactivity with IAV strains of different subtypes. (A), Amino acid sequence ... Figure 3. MAb 19H9 displays broad.

Supplementary Figure 1 IP: IgG HA 3HA-E2F1: cIAP1: wt K

14-3-3σ Regulates Keratinocyte Proliferation and Differentiation by Modulating Yap1 Cellular Localization Sumitha A.T. Sambandam, Ramesh B. Kasetti,

Yuko Oda, Lizhi Hu, Vadim Bul, Hashem Elalieh, Janardan K

Regulatory interactions of αβ and γλ T cells in glomerulonephritis

Figure Overview.

Volume 1, Issue 3, Pages (September 2007)

Figure Overview.

SDC 3 - Figure S2 % of splenic CD4+CD25+Foxp3+ T cells d8 d15 d20.

Volume 74, Issue 6, Pages (September 2008)

Volume 7, Issue 6, Pages (December 2016)

Significant differences in translational efficiencies of DNA damage repair pathway genes between patient clusters. Significant differences in translational.

3 times tables.

6 times tables.

Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy

Anti-CD96 combines with anti–CTLA-4 or anti–PD-1 to suppress experimental and spontaneous lung metastases. Anti-CD96 combines with anti–CTLA-4 or anti–PD-1.

CD8+ T cells were immunomodulated and required for the efficacy of anti–4-1BB/anti–PD-1 combination treatment. CD8+ T cells were immunomodulated and required.

Urokinase is a Positive Regulator of Epidermal Proliferation In Vivo

FIGURE 7-1 Block Diagram of Memory

Benjamini & Hochberg-corrected p < 0.05 Bonferroni-corrected

Eric B. Brandt, PhD, Melissa K. Mingler, MS, Michelle D

Mary O'Riordan, Rudolf Grosschedl Immunity

Anti-Flk-1 treatment inhibits growth of s. c. 4T1 and B16 tumors. s. c

Chapter 1 Functions.

Figure 5-1 Molecular Biology of the Cell (© Garland Science 2008)

Volume 13, Issue 21, Pages (October 2003)

A B C Name Sequence TIMP3 promoter

Suchitra D. Gopinath, Ashley E. Webb, Anne Brunet, Thomas A. Rando

Presentation transcript:

-11.9 kb -4.2 kb -5.6 kb Gfi1 +/1b neo Gfi1 +/+ Gfi1 +/1b Gfi1 1b/1b Gfi1 +/1b Gfi1 +/ kb kb Gfi1 +/+ Gfi1 +/1b -14 kb - 8 kb B A Gfi1 +/+ Gfi1 +/1b Gfi1 1b/1b Gfi1 (55 kDa) Gfi1b (37 kDa) loading control C Supp. Figure 1

Gfi1 +/+ Gfi1 P2A/P2A - 15 kb - 8 kb B Gfi1 +/P2A Gfi1 +/ kb - 8 kb Gfi1 +/P2A Gfi1 P2A/P2A Gfi1 +/+ Gfi1 -/- Gfi1 (55kDa) loading control A Supp. Figure 2

∆ Rn cycle Amplification Plot Gfi1 1b/1b E E E E E+1 Gfi1 Gfi1b E E E E E+1 Gfi1 Gfi1b Amplification Plot Gfi1 +/+ A B Gfi1 Gfi1b GAPDH Gfi1 +/+ Gfi1 1b/1b H 2 O Supp. Figure 3

IP: anti Gfi1b We: anti PIAS3 PIAS IP: anti Gfi1b We: anti Gfi1b Input IP anti-GSTIP anti-Gfi1b Gfi1b IgG Supp. Figure 4

Table 1 Differential cell counts of wild type, Gfi1 -/-, Gfi1 P2A/P2A and Gfi1 1b/1b mice Supp. Table 1  significant